CClinicalTrials.gg
CompletedNCT03703609TELEYOGAUpdated Nov 22, 2023

Effects of Tele-yoga in Long-term Conditions

An interventional study of Tele-yoga in Chronic Disease, sponsored by Linkoeping University. Completed at 4 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-22.

Sponsored by Linkoeping University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
311
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Long-term illness is common in the Swedish population, especially among older people. These conditions are often associated with impaired quality of life due to high physical and psychological symptom-burden. Medical Yoga is a therapeutic form of Kundalini Yoga with simple movements, breathing exercises and meditation. For people with serious long-term illness, it can be difficult to attend regular yoga-classes. In this study, the investigators therefore set out to develop a tele-yoga intervention and evaluate the impact of medical yoga remotely at home with regard to physical function, quality of life, symptoms of anxiety and depression, biomarkers, sleep and cognition in people with long-term conditions. Health care utilisation as well as satisfaction and experiences with the exercise form and technology used will also be assessed. The evaluation will be conducted in 150 people with long-term illness recruited from three hospitals (one university hospital and two county hospital) randomised to receive either an intervention with medical yoga remotely at home (tele-yoga) for 12 weeks or a control group receiving individualised training to the same extent. The tele-yoga intervention will be provided remotely in the home via a video-transferred yoga instructor twice a week using a tablet and an app for individual daily exercise. Data will be collected at baseline, after 3 and 6 months.

Despite evidence that physical activity improves quality of life and functional capacity and probably survival, it is difficult to motivate and enable elderly people with long-term conditions to engage in physical and mental rehabilitation. In this study, we will test whether a new method conveyed through a technical solution remotely can increase patients' activity and well-being through allowing tele-yoga at home. Can health care resources be reduced, financial gains can also be made.

The study aims to evaluate the impact of medical yoga remotely at home with regard to physical function, quality of life, symptoms of anxiety and depression, biomarkers, sleep and cognition in people with long-term conditions. The investigators will also measure health care utilisation as well as satisfaction and experiences with the exercise form and technology used. The evaluation will be conducted in 300 people with long-term illness randomised to either tele-yoga or a control group.

Read the detailed description

A sub-study will be conducted exploring physiological effects of yoga in participants with heart failure. The sub-study will include 40 of the patients with heart failure included in the main study. In the sub-study six additional measures will be performed at baseline and after 3 months in 20 study participants with heart failure in the intervention group; ergospirometry, echocardiography, Holter ECG, microcirculation using the epos system, maximal inspiratory and expiratory pressure. There will be four additional measures in 20 participants from the control-group at baseline and after 3 months; Holter ECG, microcirculation using the epos system and maximal inspiratory and expiratory pressure.

02

Conditions studied

  • Chronic Disease

Browse trials for

Keywords

  • yoga
  • rehabilitation
  • physical activity
  • quality of life
  • anxiety
  • depression
03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 179 are open to participants now.

This study's enrollment of 311 is above the median of 120 across 722 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Linkoeping University is the lead sponsor of 189 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Long-term illness and cared for at the cardiology clinic or intensive care clinic for at least 48 hours in the last 3-36 months.
  • Clinically stable condition at the inclusion.

Exclusion criteria

Exclusion Criteria:

  • Inability to fill in questionnaires.
  • Inability to participate in the intervention.
  • Expected survival of less than 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
311 participants (actual)

Study arms

  • Experimental
    Tele-yoga

    Intervention of doing medical yoga at home (tele-yoga) using (1) an online videoconference system (zoom) for particpating in group-yogaled by a live yoga instructor for 60 minutes twice a week and (2) daily individual yoga for a minimum of 10 minutes using a yoga-app. Participants are provided with a tablet with conference system zoom and yoga app for 12 weeks

    Behavioral: Tele-yoga

  • No intervention
    Individual physical activty advice

    The active control group will receive advice to be physically active that corresponds to the intervention group in time and effort, equivalent to 60 minutes for 2 days a week and a minimum of 10 minutes for 5 days a week. To compensate for the extra attention received by the intervention group by the instructor via tele-yoga group, the participants in the activecontrol group's patients will be dialed or have SMS contact (the participant chooses a type of contact) with a physiotherapist or nurse after 2, 4, 8 and 12 weeks.

Interventions

  • BehavioralTele-yoga

    Participants will get a 60 min tele-yoga session biweekly led by a certified medical yoga instructor via live videoconference link on the participants tablet. Each participant will perform a total of 20-24 yoga instructor-led sessions over a 12-week period. A session will contain 10 min breathing exercises, 40 min of yoga and 10 min relaxation/meditation. Before and at the end of each session, participants can discuss their experiences or ask questions to the instructor online. The tablet also includes an app with instructions (text, pictures, and sound files) for yoga positions, breathing and meditation. Participants are encouraged to practice yoga at home individually with one goal of one session a day for a minimum of 10 minutes.

06

What researchers measure

Primary outcomes

  1. Composite end-point including physical fuction, health-related quality of life and symptoms of anxiety and depression.

    The composite weighed score consists of physical ability (6 min walking test), Health-realted quality of Life (EQ-5D) and symptom of anxiety and depression (HADS). Based on the change in these 3 variables, a patient can get a score between -3 and + 3 based on the increase, decrease or no change in 6 min walk test, HADS, and EQ5D. The weighted variable will be categorised as improved, deteriorated or unchanged after 3 months.

    Time frame: 3 months

Secondary outcomes

  1. Aerobic capacity/endurance

    6 min walk test is a sub-maximal exercise test used to assess aerobic capacity and endurance. Measures the distance in meters covered over a time of 6 minutes

    Time frame: 3 and 6 months

  2. Symptoms of Anxiety and Depression

    Hospital anxiety and depression scale is a 14 item scale that generates ordinal data 0-3. Seven of the items relate to anxiety, range 0-21 and seven relate to depression, range 0-21.

    Time frame: 3 and 6 months

  3. Health-related quality of life

    The EQ-5D comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The responses generate ordinal data from 1-5 for each dimension. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale 0-100 mm, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

    Time frame: 3 and 6 months

  4. Physical activity

    Actigraph

    Time frame: 3 and 6 months

  5. Cognition

    Montreal Cognitive Assessment including short-term memory, visual abilities, executive functions, attention, concentration, working memory, language and orientation to time and place. Scores range between 0 and 30. A score of 26 or over is considered to be normal.

    Time frame: 3 and 6 months

  6. Sleep

    Minimal insomnia symptom scale is a sleep questionnaire with 3 items that generates ordinal data. Range 0-12.

    Time frame: 3 and 6 months

  7. Exercise Motivation

    The Exercise Motivation Index includes 15 items that generates ordinal data on the motives of participating in physical exercise. Range 0-60.

    Time frame: 3 and 6 months

  8. Lower body strength

    Sit to stand test measure the number of uprising from a chair during 30 seconds.

    Time frame: 3 and 6 months

  9. Gait speed

    Gait speed test meaures the time it takes in seconds to walk 10 meter at self-selected pace.

    Time frame: 3 and 6 months

  10. Health Health

    One general health question from RAND 36 genreating an ordinal data response from 1 (poor health)-5 (excellent health).

    Time frame: 3 and 6 months

  11. Life satisfaction

    Cantril ladder of Life is a measurement technique that asks people to rate their present, past, and anticipated future satisfaction with life on a scale anchored by their own identified values from 1 to 10.

    Time frame: 3 and 6 months

Other outcomes

  1. HcCRP

    High sensitivity C-reactive protein (CRP) will be used as a routine marker of inflammation. Blood samples were collected while the patients were at rest in a supine position using EDTA-vials. The vials were chilled on ice before centrifugation at 3000 g, 4oC and then frozen at -70ºC. No sample was thawed more than twice. CRP was analysed using latex-enhanced turbidimetric immunoassay (Roche Diagnostics GmbH, Vienna, Austria) with a lower detection limit of 0.03 mg/L and coefficient of variation of 1.7%.

    Time frame: 3 and 6 months

  2. Cost-effectiveness

    Health care utilisation through medical charts/registries. The cost of the intervention will also be calculated.

    Time frame: 6 months

  3. Adherence

    The adherence will be measured through attendance in video groups and the use of yoga app The minutes each participant have used to perform individual yoga training will be measured via a statistical software incorporated in the yoga app.

    Time frame: 3 months

  4. Qualitative interviews

    Telephone interviews about yoga, tele-yoga, user-friendliness and use of technology in the tele-yoga group

    Time frame: 3 months

  5. Quality-adjusted life-year (QALY)

    Will be obtained from the EQ-5D

    Time frame: 6 months

07

Study locations

4 sites
  • Mälardals hospital
    Eskilstuna, Sweden
  • Ryhov hospital
    Jönköping, Sweden
  • Linköpings University hospital
    Linköping, Sweden
  • Vrinnevi Hospital
    Norrköping, Sweden
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03703609
Lead sponsor
Linkoeping University
Responsible party
Anna Stroemberg (professor, Linkoeping University) — Principal investigator
First posted
Oct 12, 2018
Start date
Oct 15, 2018
Primary completion
May 31, 2023
Completion
May 31, 2023
Last update
Nov 22, 2023

Study contacts

Anna Stromberg, PhD
principal investigator · Linkoping University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion